Peer Review Process
Upon receipt, competing applications will be reviewed both by the Center for Scientific Review (CSR) and the National Cancer Institute (NCI) for completeness and for conformance to all eligibility requirements and special provisions and requirements. Incomplete applications will be returned to the applicant without further consideration.
Applications will be evaluated for scientific and technical merit by an appropriate Scientific Review Group (assignments will be shown in the eRA Commons), in accordance with NIH peer review policy and procedures, using the stated review criteria.
As part of the scientific peer review, all applications:
- May undergo a committee process in which only those applications deemed to have the highest scientific and technical merit (generally the top half of applications under review), will be discussed and assigned an overall impact/priority score and a percentile indicating the application's relative standing among applications reviewed in the same study section. Applications that are not discussed will not be assigned an overall impact/priority score or a percentile.
- Will receive the reviewers' comments or "summary statement" approximately one month after the study section meets.
Applications will be assigned on the basis of established PHS referral guidelines to the appropriate NIH Institute or Center. Applications will compete for available funds with all other recommended applications submitted in response to this Funding Opportunity Announcement. Following initial peer review, recommended applications will receive a second level of review by the NCI. The following will be considered in making funding decisions:
- Scientific and technical merit of the proposed project as determined by scientific peer review.
- Availability of funds.
- Relevance of the proposed project to program priorities.
For review criteria for the F30 grant mechanism, see the Review Criteria section of the Program Announcement.